跳到正文
原文
Nature 健康护理主题·· 21 天前AI 评分35

下一代测序策略在泰国家族性高胆固醇血症筛查中的成本效益分析

Evaluating the cost-effectiveness of next-generation sequencing strategies for familial hypercholesterolemia cascade screening in Thailand

AI 导读

研究采用决策树-马尔可夫混合模型评估了泰国家族性高胆固醇血症(FH)筛查中不同基因检测方法的成本效益。结果显示,基于panel检测和全外显子测序(WES)的筛查策略均优于常规治疗,分别每质量调整生命年成本为81,494泰铢和74,641泰铢。

正文

Abstract

Background:

Genetic cascade screening of familial hypercholesterolemia (FH) effectively prevents cardiovascular complications, but it remains unclear how health systems should roll out genetic testing over time. We developed a policy-relevant, forward-looking framework for stepwise economic evaluation on genetic testing, using FH cascade testing in Thailand as a case study.

Methods:

We constructed a decision tree-Markov hybrid model for a cohort of 35-year-old probands with low-density lipoprotein cholesterol above 4.9 mmol/L and their first- and second-degree relatives. We performed stepwise evaluations on conventional three-gene panel testing, whole-exome sequencing (WES), and onward to emerging long-read sequencing (LRS), compared with standard of care from a societal perspective. Conventional economic evaluation compared panel testing and WES using currently available evidence, while early economic evaluation was applied to LRS to identify target product profiles and explore uncertainties.

Results:

The analyses show that panel- and WES-based cascade screening are cost-effective versus standard of care, with incremental cost-effectiveness ratios (ICERs) of Thai baht (THB) 81,494 (€2,146/$2,371) and THB 74,641 (€1,966/$2,172) per quality-adjusted life-year (QALY), respectively. Compared with panel testing, WES generates 0.055 incremental QALYs at an ICER of THB 50,703 (€1,335/$1,475)/QALY. LRS is also cost-effective versus standard of care under target costs and yields 0.04 incremental QALYs/person versus WES, but requires cost reductions of 16.33% to THB 33,468/proband and 46.05% to THB 21,580/proband to surpass WES and dominate the market, respectively.

Conclusions:

This forward-looking, stepwise evaluation demonstrates that next-generation sequencing for FH cascade testing can be economically viable in Thailand while advancing precision health under universal healthcare.

Plain language summary

Familial hypercholesterolemia (FH) is an inherited condition that causes very high cholesterol levels and increases the risk of early heart disease and stroke. Many people with FH are not diagnosed. Testing the relatives of someone with FH can help identify affected family members early so they can receive treatment. In this study, we evaluated different genetic testing methods for conducting FH cascade testing in middle-income countries with universal health coverage, such as Thailand. Our results suggest that whole-exome sequencing provides greater health benefits with good value for money compared to standard of care and conventional three-gene panel, while emerging long-read sequencing may offer even greater benefits in the future with expected cost reductions. These findings support cost-effective stepwise implementation of next-generation sequencing to improve precision health in Thailand and similar health systems.

Funding

This study was funded by the Health Systems Research Institute (HSRI), Thailand (HSRI 66-099). The development of LRS for FH detection was led by Vorasuk and his team, funded by the Health Systems Research Institute (HSRI), Thailand (HSRI 68-082). The study also received partial funding support from the Saw Swee Hock School of Public Health, National University of Singapore, and the Health Intervention and Technology Assessment Program of Thailand. The Health Intervention and Technology Assessment Program Foundation (HITAP) is a research unit in Thailand, and supports evidence-informed priority-setting and decision-making for health. HITAP is funded by national and international public funding agencies. HITAP is supported by the Thailand Science Research and Innovation (TSRI) Fundamental Fund. The funders had no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.

Author information

Author notes

  1. These authors jointly supervised this work: Yot Teerawattananon, Wenjia Chen.

Authors and Affiliations

  1. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore

    Yue Zhang, Jing Lou, Hwee-Lin Wee, Yot Teerawattananon & Wenjia Chen

  2. Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Bangkok, Thailand

    Dimple Butani & Yot Teerawattananon

  3. Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand

    Parnnaphat Luksameesate, Sutinee Soopairin, Chanthawat Patikorn, Pawarut Wongmanovisut & Thanapol Khuharatanachai

  4. Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand

    Vorasuk Shotelersuk

  5. Center of Excellence for Medical Genomics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

    Vorasuk Shotelersuk & Chanatjit Cheawsamoot

  6. Division of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand

    Nattanichcha Kulthanachairojana

  7. Division of National Drug Policy, Food and Drug Administration Thailand, Nonthaburi, Thailand

    Pawarut Wongmanovisut

  8. Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore

    Hwee-Lin Wee

  9. Department of Medicine, Faculty of Medicine, Chulalongkorn University and Excellence Center in Diabetes, Hormones and Metabolism, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    Weerapan Khovidhunkit

  10. Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

    Poranee Ganokroj

Authors

  1. Yue Zhang
  2. Parnnaphat Luksameesate
  3. Vorasuk Shotelersuk
  4. Jing Lou
  5. Sutinee Soopairin
  6. Chanthawat Patikorn
  7. Nattanichcha Kulthanachairojana
  8. Pawarut Wongmanovisut
  9. Thanapol Khuharatanachai
  10. Hwee-Lin Wee
  11. Weerapan Khovidhunkit
  12. Poranee Ganokroj
  13. Chanatjit Cheawsamoot
  14. Dimple Butani
  15. Yot Teerawattananon
  16. Wenjia Chen

Corresponding author

Correspondence to Wenjia Chen.

Ethics declarations

Competing interests

W.C. has received research funding from Illumina, Inc. The funder had no role in the design, conduct, analysis, interpretation of the study, or preparation of the manuscript. All other authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Luksameesate, P., Shotelersuk, V. et al. Evaluating the cost-effectiveness of next-generation sequencing strategies for familial hypercholesterolemia cascade screening in Thailand. Commun Med (2026). https://doi.org/10.1038/s43856-026-01953-4

Download citation

  • Received: 21 April 2026

  • Accepted: 24 September 2026

  • Published: 30 October 2026

  • DOI: https://doi.org/10.1038/s43856-026-01953-4

来源:Nature 健康护理主题 · nature.com